The global blood collection market is expected to reach USD 7.82 Billion in 2028 and register a steady revenue CAGR of 6.2% over the forecast period, according to latest report published by Reports and Data. Key factors driving global market revenue growth are increasing prevalence of various diseases, rising number of accidents, organ transplantations and surgeries, and increasing number of product approvals. 

Blood collection is one of the most common methods used for diagnosing various healthcare conditions. In the recent years, there has been a rapid increase in various health conditions such as cardiovascular diseases and cancer across the globe. Blood is collected for various blood tests for diagnosis and treatment of diseases. Increasing prevalence of blood diseases such as anemia, blood clots, leukemia, and sickle cell disease and rising need for regular blood testing are fueling global market growth. In addition, increasing awareness about blood donation, rising need for blood transfusion in emergencies, road accidents, and surgeries, and increasing investments for developing cost-effective products are expected to fuel global market growth going ahead.  

However, factors such as lack of sufficient blood testing, especially in developing countries, high prices of automated blood collection devices, and complications regarding shipping and storing blood are expected to hamper overall market growth during the forecast period.

In-depth Study of the Competitive Landscape:

The global Blood Collection market consists of various market players, which make this business sphere highly competitive. In this section of the report, the authors have provided authentic information on product portfolios, new product innovations, technological capabilities, and product pricing strategies of each of these players. Moreover, it discusses the key strategies implemented by these players, such as mergers acquisitions, joint ventures, collaborations, partnerships and agreements, to build on their market presence.

Top companies profiled in the report include:

Becton, Dickinson and Company, Terumo BCT, Inc., Fresenius Kabi AG, Grifols, Nipro Medical Corporation, Quest Diagnostics, Macopharma S.A., Smiths Medical, Kawasumi Laboratories, Retractable Technologies, Liuyang Sanli Medical Technology Development, F.L. Medical S.R.L, AB Medical, Micsafe Medical Group Limited, CML Biotech, Lmb Technologie GmbH, and Greiner Holding AG

Key Market Regions Covered in the Report:

  • North America (U.S., Canada)
  • Europe (U.K., Italy, Germany, France, Rest of EU)
  • Latin America (Chile, Brazil, Argentina, Rest of Latin America)
  • Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
  • The Middle East Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)

Product Outlook (Revenue, USD Billion, 2018-2028)

  • Blood Collection Tubes
    • Plasma/Whole-Blood Tubes
    • EDTA Tubes
    • Heparin Tubes
    • Coagulation Tubes
    • Glucose Tubes
    • ESR Tubes
    • Serum Tubes
    • Vacuum Tubes
    • Non-vacuum Tubes
  • Needles Syringes
  • Blood Bags
  • Blood Collection Systems/Monitors
  • Lancets

Method Outlook (Revenue, USD Billion, 2018-2028)

  • Manual
  • Automated

Application Outlook (Revenue, USD Billion, 2018-2028)

  • Diagnostics
    • Infectious Diseases
    • Non-infectious Diseases
  • Therapeutics

End Use Outlook (Revenue, USD Billion, 2018-2028)

  • Hospitals, Ambulatory Surgical Centers, Nursing Homes
  • Diagnostic Pathology Laboratories
  • Blood Banks
  • Others

Some key highlights from the report:

    • Based on product, the blood collection tubes segment is expected to account for significant revenue share over the forecast period owing to high prevalence of various chronic diseases, increasing blood testing, availability of different testing tubes for diagnosis of different diseases, and increasing focus on developing more advanced tubes for collecting blood. 
    • Among the application segment, the diagnostics segment is expected to account for significantly larger share during 2021-2028 owing to increasing prevalence of diabetes, cancer, cardiovascular disorders, high usage of blood collection devices for diagnosing infections, and increasing awareness about regular health checkups.  
    • Based on end use, the hospitals, ambulatory surgical centers, nursing homes segment is expected to account for largest revenue share during the forecast period owing to increasing prevalence of various diseases, large number of patient admissions for accidents, trauma, and other emergencies, and rising number of surgeries and organ transplantation. 
    • Europe is expected to account for significant revenue share over the forecast period owing to increasing prevalence of chronic diseases, availability of advanced healthcare facilities, rising number of accidents and emergencies, and increasing blood testing volume. In addition, increasing awareness about blood donation and early detection of diseases, increasing number of clinical trials, and rising investments in research and development activities are boosting market growth in Europe. 
    • Asia Pacific market revenue is expected to expand at a rapid CAGR during 2021-2028 owing to increasing healthcare expenditure, improving healthcare infrastructure, high patient pool, and rising number of blood donation events, campaigns organized by various public and private organizations. Other factors such as rising per capita income, increasing investments for developing advanced devices for collecting blood, increasing number of road accidents and surgeries are fueling Asia Pacific market growth. 

Request a Sample Report on Blood Collection Market @ https://www.reportsanddata.com/sample-enquiry-form/4183 

Thank you for reading our report. Do connect with us in case of any more queries about the report and its customization. Our team will ensure the report is well suited to cater to your needs.

Get More Reports:

Drugs of Abuse Testing Services Market @ https://www.reportsanddata.com/report-detail/drugs-of-abuse-testing-services-market

Hematology Diagnostics Market @ https://www.reportsanddata.com/report-detail/hematology-diagnostics-market

Neuroscience Antibodies and Assays Market @ https://www.reportsanddata.com/report-detail/neuroscience-antibodies-and-assays-market

Mannitol Injection Market @ https://www.reportsanddata.com/report-detail/mannitol-injection-market 

About Reports and Data

Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.